MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.5 USD | -0.58% |
|
-2.80% | +16.97% |
| 05-02 | Merck: encouraging results in gastric cancer | CF |
| 05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 323B | ||||||
| 662B | ||||||
| 546B | ||||||
| 359B | ||||||
| 290B | ||||||
| 234B |
